Ticker Details
Travere Therapeutics, Inc.
IPO Date:	August 15, 2003
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.13B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.50 | 2.56%
Avg Daily Range (30 D):	$0.97 | 2.42%
Avg Daily Range (90 D):	$0.86 | 2.70%

Institutional Daily Volume
Avg Daily Volume:	.4M
Avg Daily Volume (30 D):	2.41M
Avg Daily Volume (90 D):	1.86M

Trade Size
Avg Trade Size (Sh.):	81
Avg Trade Size (Sh.) (30 D):	77
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	4,252
Avg Institutional Trade:	$2.26M
Avg Institutional Trade (30 D):	$3.22M
Avg Institutional Trade (90 D):	$3.1M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$3.45M
Avg Closing Trade (30 D):	$10.69M
Avg Closing Trade (90 D):	$7.58M
Avg Closing Volume:	178.56K

News

May 10, 2026 @ 1:16 PM Validating headline phrasing and editorial resonan... Source: Seena Hassouna

Feb 27, 2026 @ 2:52 PM Your Kidneys Count: American Kidney Fund Urges Ame... Source: American Kidney Fund

Jan 31, 2026 @ 1:50 AM TVTX ALERT: Investigation Launched into Travere Th... Source: Robbins Geller Rudman & Dowd Llp

Jan 13, 2026 @ 11:58 PM TVTX ALERT: Investigation Launched into Travere Th... Source: Robbins Geller Rudman & Dowd Llp

Dec 24, 2025 @ 11:31 PM Why Travere Therapeutics Stock Popped by Nearly 14... Source: Eric Volkman

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.4	$.03	$-.29
Diluted EPS	$-.4	$.03	$-.29
Revenue	$127.2M	$129.69M	$490.73M
Gross Profit	$125.25M	$127.14M	$480.39M
Net Income / Loss	$-37.1M	$2.73M	$-25.55M
Operating Income / Loss	$-36.92M	$-32.43M	$-62.82M
Cost of Revenue	$1.95M	$2.55M	$10.34M
Net Cash Flow	$-14.67M	$-17.9M	$34.5M
PE Ratio

Splits
Nov 08, 2011	1:9